GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
N

Nuformix NFX.L · GBp

Health Care · LSE · 🇬🇧 United Kingdom

Compare

0.11p

0.00%

Close of 9 Nov 2026, in pence

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Nuformix — daily NFX

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Nuformix on TradingView ↗
Market value
£1.7m
Last close × shares
Volume
3.5m
Shares, 9 Nov 2026

About Nuformix

Its shares trade on LSE under the ticker NFX.L. It has been listed since 17 December 2015. In the fiscal year to 31 March 2021, it reported revenue of £50,000 and a net loss of £1.1m. At that date it held total assets of £5.0m and shareholders' equity of £4.7m.

Nuformix Plc is a pharmaceutical development company, which targets unmet medical needs in fibrosis and oncology via drug repurposing. The firm is engaged in targeting unmet medical needs in fibrosis and oncology via drug repurposing. Its clinical pipeline includes NXP001, NXP002, and NXP004. NXP002 is its pre-clinical lead asset and a potential inhaled treatment for idiopathic pulmonary fibrosis (IPF) and possibly other fibrosing interstitial lung diseases (ILDs). NXP001 is a form of the drug aprepitant that is marketed as a product in the oncology supportive care setting (chemotherapy-induced nausea and vomiting). NXP004 is a form of Olaparib, which is used for the treatment of adults with advanced ovarian cancer and deleterious or suspected deleterious germline BRCA mutation.

Figures and description from our data supplier, not checked against the company's own report.

More about Nuformix →

Latest on Nuformix

Our reporting

We have not reported on Nuformix yet.

Next results

2 Dec 2026

Due on 2 Dec 2026.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Nuformix's ticker?

Nuformix trades as NFX.L on LSE, under ISIN GB00BYW79Y38.

What was Nuformix's last closing price?

0.11p on 9 Nov 2026. The figure is in GBp and is never converted.

When does Nuformix next report results?

Results are expected on 2 Dec 2026, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.